Dreyfus Andrew 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Jun 12, 2025
Insider Transaction Report
Form 4
Dreyfus Andrew
Director
Transactions
- Award
Class A Common Stock
2025-06-10+45,000→ 228,313 total
Footnotes (2)
- [F1]The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.
- [F2]Since the date of the reporting person's last ownership report, the individual transferred 4,917 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse.